Mental Health Services
Cancer Registry, Ministry of Health, Jerusalem
Gertner Institute, Tel Hashomer Hospital, Tel Hashomer
Department of Information and Evaluation, Mental Health Services, Ministry of Health, Jerusalem, Israel
Department of Psychiatry and Human Behavior, Brown University, Providence, Rhode Island, USA
Cancer Registry
Mental Health Services, Ministry of Health, Jerusalem
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
Correspondence: Dr Itzhak Levav, Ministry of Health, 2 Ben Tabai Street, Jerusalem 91010, Israel. Tel: +972 2 568 1429; fax: +972 2 672 5822; email: Itzhak.Levav{at}moh.health.gov.il
Declaration of interest None. Funding detailed in Acknowledgements.
Background A reduced risk of cancer has been noted among people with schizophrenia. Given that genetic causes have been proposed as an explanation of this finding, one would expect that the risk of cancer among first-degree relatives would be equally reduced.
Aims To investigate the risk of cancer among the biological parents and full siblings of people receiving in-patient care for schizophrenia.
Method Linkage analysis was conducted between national population, psychiatric and cancer databases. Standardised incidence ratios for all cancer sites were calculated by comparing the incident rates among first-degree relatives with national incidence rates.
Results A reduced cancer risk was found across all groups examined. Among parents, whose numbers were adequately large, the findings reached statistical significance. For index cases and siblings a markedly younger population only a trend was elicited.
Conclusions The genetic hypothesis namely, the presence of a gene with the dual effect of reducing the cancer risk and disrupting neurodevelopment is a plausible explanation for these findings.
Related articles in BJP:
This article has been cited by other articles:
![]() |
B. Kirkpatrick, E. Messias, P. D. Harvey, E. Fernandez-Egea, and C. R. Bowie Is Schizophrenia a Syndrome of Accelerated Aging? Schizophr Bull, November 1, 2008; 34(6): 1024 - 1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Tan, Y. Wang, B. Gold, J. Chen, M. Dean, P. J. Harrison, D. R. Weinberger, and A. J. Law Molecular Cloning of a Brain-specific, Developmentally Regulated Neuregulin 1 (NRG1) Isoform and Identification of a Functional Promoter Variant Associated with Schizophrenia J. Biol. Chem., August 17, 2007; 282(33): 24343 - 24351. [Abstract] [Full Text] [PDF] |
||||
Read all eLetters